Goswami B B, Koch W H, Cebula T A
Division of Molecular Biological Research and Evaluation, Food and Drug Administration, Washington, DC 20204.
Biotechniques. 1994 Jan;16(1):114-5, 118-21.
PCR was used to introduce a 63-bp deletion into the putative RNA replicase coding sequence of hepatitis A virus. RNA was synthesized in vitro from the deletion mutant cloned into a transcription vector. Upon amplification by PCR, cDNA made from the competitor RNA generated an amplified fragment that could be easily distinguished from the product generated from wild-type hepatitis A virus genomic RNA by gel electrophoresis, when the same primers were used, without further manipulation. The competitor RNA was used as a positive control in PCR-based detection of very low copy numbers of hepatitis A virus genomic RNA in the presence of unrelated hard-shell clam RNA. When the competitor RNA was used for competitive PCR to quantitate wild-type RNA, the presence of one template at a 10-fold to 100-fold higher level almost completely inhibited product formation from the underrepresented template. The competitor RNA should be useful as a control for reverse transcription and PCRs to determine hepatitis A virus genome RNA when accidental contamination of test samples by a wild-type positive control template would compromise the results.
采用聚合酶链反应(PCR)在甲型肝炎病毒假定的RNA复制酶编码序列中引入一个63碱基对的缺失。从克隆到转录载体中的缺失突变体在体外合成RNA。当使用相同引物时,通过PCR扩增,由竞争RNA制备的cDNA产生的扩增片段在凝胶电泳中可轻松与野生型甲型肝炎病毒基因组RNA产生的产物区分开来,无需进一步处理。在存在无关的硬壳蛤RNA的情况下,竞争RNA用作基于PCR检测极低拷贝数甲型肝炎病毒基因组RNA的阳性对照。当竞争RNA用于竞争性PCR定量野生型RNA时,一种模板的存在水平比另一种高10倍至100倍几乎完全抑制了代表性不足模板的产物形成。当野生型阳性对照模板意外污染测试样品会影响结果时,竞争RNA应作为逆转录和PCR的对照,用于确定甲型肝炎病毒基因组RNA。